share_log

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Lowers Price Target to $34

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Lowers Price Target to $34

HC Wainwright & Co.重申买入库里南肿瘤学,将目标股价下调至34美元
Benzinga ·  2023/08/11 13:10

HC Wainwright & Co. analyst Edward White reiterates Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $49 to $34.

HC Wainwright & Co. 分析师爱德华·怀特重申了库里南肿瘤学(纳斯达克股票代码:CGEM)的买入,并将目标股价从49美元下调至34美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发